[1]
Bhavsar, D. 2026. Adverse Event Label Expansion for GLP-1 Medications Due toOff-‎Label Use: Regulatory Implications and Challenges. International Journal of Basic and Applied Sciences. 14, 8 (May 2026), 702–709. DOI:https://doi.org/10.14419/n99q9v48.